Rocket Pharmaceuticals Warrant
RCKTW
14 hedge funds and large institutions have $2.38M invested in Rocket Pharmaceuticals Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.
94% more capital invested
Capital invested by funds: $1.22M → $2.38M (+$1.15M)
0.55% less ownership
Funds ownership: 3.35% → 2.79% (-0.55%)
18% less funds holding
Funds holding: 17 → 14 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$8.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$15K |
| 2 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
-$13.5K |
| 3 |
Walleye Capital
New York
|
-$11K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.82K |
| 5 |
HF
HRT Financial
New York
|
-$1K |
RCKTW Hedge Fund Activity: Q4 2023 in Review
14 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals Warrant (RCKTW) for Q4 2023, worth a combined $2.38M — up 94% from $1.22M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of RCKTW and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 0 added.
The largest buyer was Cowen and Company, opening a new position worth an estimated $8.8K. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $15K sold.
- 14 institutional investors held Rocket Pharmaceuticals Warrant (RCKTW) as of Q4 2023, down from 17 in Q3 2023.
- Funds reported $2.38M of Rocket Pharmaceuticals Warrant stock for Q4 2023, up 94% quarter-over-quarter.
- 1 fund opened new Rocket Pharmaceuticals Warrant positions in Q4 2023 and 4 closed out, a net change of -3 holders.
- The largest Rocket Pharmaceuticals Warrant buyer in Q4 2023 was Cowen and Company, an estimated $8.8K added.
- The largest Rocket Pharmaceuticals Warrant seller in Q4 2023 was Radcliffe Capital Management, an estimated $15K sold.
Based on aggregated 13F filings for Q4 2023.